Semicarbazide-sensitive amine oxidase activity of guinea pig dorsal skin. 1994

F Buffoni, and S Cambi, and G Banchelli, and G Ignesti, and R Pirisino, and L Raimondi
Department of Pharmacology, University of Florence, Italy.

A semicarbazide-sensitive amine oxidase activity with a high affinity for benzylamine (Bz.SSAO) (E.C. 1.4.3.6) is present in guinea pig dorsal skin. This enzymic activity oxidized benzylamine, histamine, 1,4-methylhistamine and acetylputrescine and was inhibited by semicarbazide and by B24 (3,5-diethoxy-4-aminomethylpyridine), a selective inhibitor of Bz.SSAO enzymes. It cross reacted with the antibodies raised against pure pig plasma benzylamine oxidase. Immunohistochemistry showed that it was localized in fibroblasts. Bz.SSAO activity of guinea pig dorsal skin increased during the process of skin healing. A treatment of the wounds with 3 micrograms of b-FGF significantly accelerated the process of skin healing and the increase of Bz.SSAO activity.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006631 Amine Oxidase (Copper-Containing) A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. Diamine Oxidase,Histaminase,Amine Oxidase, Copper-Containing,Copper Amine Oxidase,Diaminobenzidine Oxidase,Semicarbazide-Sensitive Amine Oxidase,Xylylene Diamine Oxidase,Amine Oxidase, Copper,Amine Oxidase, Copper Containing,Amine Oxidase, Semicarbazide-Sensitive,Copper-Containing Amine Oxidase,Diamine Oxidase, Xylylene,Oxidase, Copper Amine,Oxidase, Copper-Containing Amine,Oxidase, Diamine,Oxidase, Diaminobenzidine,Oxidase, Semicarbazide-Sensitive Amine,Oxidase, Xylylene Diamine,Semicarbazide Sensitive Amine Oxidase
D000587 Oxidoreductases Acting on CH-NH Group Donors Enzymes catalyzing the dehydrogenation of secondary amines, introducing a C Secondary Amine Oxidoreductases,Amine Oxidoreductases, Secondary Amine,Amine Oxidoreductases, Secondary,Oxidoreductases Acting on CH NH Group Donors,Oxidoreductases, Secondary Amine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012663 Semicarbazides Derivatives of UREA where one of the amino groups is replaced with hydrazine.
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

F Buffoni, and S Cambi, and G Banchelli, and G Ignesti, and R Pirisino, and L Raimondi
February 2002, Life sciences,
F Buffoni, and S Cambi, and G Banchelli, and G Ignesti, and R Pirisino, and L Raimondi
October 2002, In vitro cellular & developmental biology. Animal,
F Buffoni, and S Cambi, and G Banchelli, and G Ignesti, and R Pirisino, and L Raimondi
January 1989, Comparative biochemistry and physiology. B, Comparative biochemistry,
F Buffoni, and S Cambi, and G Banchelli, and G Ignesti, and R Pirisino, and L Raimondi
July 1990, Research communications in chemical pathology and pharmacology,
F Buffoni, and S Cambi, and G Banchelli, and G Ignesti, and R Pirisino, and L Raimondi
May 1998, Molecular genetics and metabolism,
F Buffoni, and S Cambi, and G Banchelli, and G Ignesti, and R Pirisino, and L Raimondi
August 2015, Molecular and cellular endocrinology,
F Buffoni, and S Cambi, and G Banchelli, and G Ignesti, and R Pirisino, and L Raimondi
November 2005, The Journal of pharmacology and experimental therapeutics,
F Buffoni, and S Cambi, and G Banchelli, and G Ignesti, and R Pirisino, and L Raimondi
December 2003, Methods and findings in experimental and clinical pharmacology,
F Buffoni, and S Cambi, and G Banchelli, and G Ignesti, and R Pirisino, and L Raimondi
July 2004, Circulation research,
F Buffoni, and S Cambi, and G Banchelli, and G Ignesti, and R Pirisino, and L Raimondi
January 1990, Journal of neural transmission. Supplementum,
Copied contents to your clipboard!